| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $188.3M | +18.1% |
| R&D Expense | $64.1M | +0.7% |
| SG&A Expense | $83.3M | +2.5% |
| Operating Income | -$34.1M | +30.4% |
| Interest Expense | $5.8M | +18.4% |
| Pre-tax Income | -$42.3M | +21.7% |
| Income Tax | $488K | +53.0% |
| Net Income | -$42.8M | +21.3% |
| EPS (Basic) | -$0.24 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.6M | -27.0% |
| Accounts Receivable | $34.4M | +37.0% |
| Inventory | $29.0M | +8.2% |
| Current Assets | $170.1M | -9.1% |
| Total Assets | $218.1M | -8.2% |
| Current Liabilities | $117.1M | +49.0% |
| Total Liabilities | $149.5M | -1.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.6M | +24.5% |
| Capital Expenditures | $2.0M | +119.8% |
| Investing Cash Flow | $8.5M | -33.3% |
| Financing Cash Flow | $4.2M | -87.8% |
| Free Cash Flow | -$27.6M | +20.7% |
| +25.0% |
| EPS (Diluted) | -$0.24 | +25.0% |
| Stockholders' Equity |
| $67.6M |
| -20.1% |